Open AccessCost-effectiveness of immunomodulators versus infliximab for adults with moderate-to-severe ulcerative colitis.
Author(s) -
Daniel C. Malone,
Jason T. Hurwitz,
J. H. Lofland,
Bijan Nejadnik,
Julie Vanderpoel,
Heidi C. Waters
Publication year - 2011
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/17.supplement1.s53b
Subject(s) - infliximab , ulcerative colitis , medicine , gastroenterology , vedolizumab , colitis , tumor necrosis factor alpha , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom